RightFit Trial Directory

Lung Cancer clinical trials in Bethesda, MD

15 recruiting lung cancer studies with a site in Bethesda, MD.

All trials in Bethesda, MD · All Lung Cancer trials

RecruitingPhase 1NCT07509034

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase not listedNCT00001465

Study of the Disease Process of Lymphangioleiomyomatosis

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Bethesda, MD

RecruitingPhase not listedNCT00001532

Role of Genetic Factors in the Development of Lung Disease

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Bethesda, MD

RecruitingPhase not listedNCT00034216

Collection of Blood From Patients With Cancer

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase not listedNCT00451022

Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 1 / Phase 2NCT04959175

Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies

Sponsor: National Cancer Institute (NCI)

Bethesda, MD · +1 more sites

RecruitingPhase 1NCT06066138

A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 1NCT06885697

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase not listedNCT00242723

Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 3NCT07144280

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Sponsor: Pfizer

Annapolis, MD · Bethesda, MD · Brandywine, MD · +238 more sites

RecruitingPhase not listedNCT00001823

Evaluation for NCI Surgery Branch Clinical Research Protocols

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 3NCT07222566

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Sponsor: Pfizer

Annapolis, MD · Bethesda, MD · Brandywine, MD · +223 more sites

RecruitingPhase 1 / Phase 2NCT05592626

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Sponsor: Marengo Therapeutics, Inc.

Bethesda, MD · +12 more sites

RecruitingPhase 2NCT06503146

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase not listedNCT05236114

GEMINI-NSCLC: NSCLC Biomarker Study

Sponsor: Tempus AI

Baltimore, MD · Bethesda, MD · +55 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.